1. Home
  2. ITOS vs TATT Comparison

ITOS vs TATT Comparison

Compare ITOS & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • TATT
  • Stock Information
  • Founded
  • ITOS 2011
  • TATT 1985
  • Country
  • ITOS United States
  • TATT Israel
  • Employees
  • ITOS N/A
  • TATT N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • TATT Aerospace
  • Sector
  • ITOS Health Care
  • TATT Industrials
  • Exchange
  • ITOS Nasdaq
  • TATT Nasdaq
  • Market Cap
  • ITOS 270.7M
  • TATT 308.2M
  • IPO Year
  • ITOS 2020
  • TATT 1987
  • Fundamental
  • Price
  • ITOS $6.67
  • TATT $34.14
  • Analyst Decision
  • ITOS Strong Buy
  • TATT Strong Buy
  • Analyst Count
  • ITOS 3
  • TATT 1
  • Target Price
  • ITOS $25.67
  • TATT $35.00
  • AVG Volume (30 Days)
  • ITOS 550.0K
  • TATT 140.6K
  • Earning Date
  • ITOS 04-28-2025
  • TATT 05-21-2025
  • Dividend Yield
  • ITOS N/A
  • TATT N/A
  • EPS Growth
  • ITOS N/A
  • TATT 96.08
  • EPS
  • ITOS N/A
  • TATT 1.00
  • Revenue
  • ITOS $35,000,000.00
  • TATT $152,116,000.00
  • Revenue This Year
  • ITOS N/A
  • TATT $18.62
  • Revenue Next Year
  • ITOS $31.74
  • TATT $10.62
  • P/E Ratio
  • ITOS N/A
  • TATT $34.74
  • Revenue Growth
  • ITOS 177.89
  • TATT 33.68
  • 52 Week Low
  • ITOS $4.80
  • TATT $11.84
  • 52 Week High
  • ITOS $18.75
  • TATT $33.83
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 49.00
  • TATT 69.05
  • Support Level
  • ITOS $6.18
  • TATT $28.58
  • Resistance Level
  • ITOS $7.80
  • TATT $33.83
  • Average True Range (ATR)
  • ITOS 0.50
  • TATT 1.93
  • MACD
  • ITOS -0.05
  • TATT 0.67
  • Stochastic Oscillator
  • ITOS 29.94
  • TATT 80.30

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: